Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So, you're selling all on "trial news", or waiting for results?
Definitely way more!!! :) :) :)
Choosing and contracting a CRO comes easy enough.
Should be the least of your worries. Its certainly become mine since the recent mishaps.
I, like most here, would agree that KW has more than likely already been in talks with one. Perhaps he’s waiting for the appropriate time to contract and spend the money. He certainly has reason to. For example, ViraSure’s hand-off was an epic failure. The setback was obviously an unexpected loss of money and time. Valuable lesson learned wouldn’t you think?
Maybe now, he prefers to have the CypCap’s, MCB, and all testing nailed down first before pulling the trigger on a CRO. jmo
Something I tend to think of quite often is that there was a lot of time spent with TD2...a lot. So, it’s highly possible that a lot of the planning and legwork is already complete. Perhaps the new CRO doesn’t really have an enormous amount of work to do. Work that would need to be done at the 11th hour, however.
Look, here you have a CEO of a biotech company who knows he potentially has a disruptive PC therapy. Time is so critical now. Every last step is critical now. I think here in the homestretch to the IND and trial, step by step, he’s trying to be as careful as possible to get us there.
Yeah, we need the CRO, but we need the MCB and CypCap’s more, do we not?
I’m sure we’ll get the CRO, but when? ....your guess is as good as mine.
Keeping the faith and remaining positive.
(((((Patience)))))
Go PharmaCyte!!!
I now think we are closer to the IND than I originally thought.
The CypCap's production began well before the MCB setback, so you'd think they should be near completion.
With the cell culture medium back in line and the MCB produced, and the live cell encapsulation already having been proven in Austrianova's cGMP compliant facility...I believe the only thing we need to achieve is successful testing.
I think we're that close to checking off the IND list.
(((((TESTING!, that's it!!!))))) :) :) :)
Let's go KW!!!!
lol What will your magical “golden cross “ tell you??? ...please enlighten us.
I totally agree RC
The production of the MCB is significant, but it was a "partial" event.
When the MCB test proves success, then we'll see the pps continue upward.
Go PharmaCyte!!!
Sure they do, and so do I. Especially, after having already proven in past clinical trials that CiaB’s “targeted chemotherapy” is effective and safe with no side effects.
And I’m not saying the opposite.....in fact, what I am expecting to roll out is exactly what was said in the CC per KW.
For me it’s like needing to complete four vital achievements before I can begin to feel really confident about this investment.
MCB
MCB testing
CypCaps
CypCap testing
One down, and just three more to go. :) :) :)
Go PharmaCyte!!!!!
lol Hey efood what else did the insiders tell you? ...good call!!! :) :) :)
Because we have nothing if the cell bank fails it’s testing.
Yes, I totally agree ...that’s exactly what I’ve been saying. :)
Tulla I received an email 3 days ago from IR and was told that PMCB has yet to contract a CRO.
Maybe they will once the CypCaps are completed... just my guess.
Almost there longs!!!! :) :) :)
Austrianova to hopefully sound the bugle next ....then it’s on!!!!
Come on CiaB!!!!
Lets go PharmaCyte!!!!!!!
NICE!!!!!!!!!!!!!
No party to go to without CypCaps.
Link??????
It can't be just "a catalyst" (singular) ...we need catalyst('s). Two to be exact. I know I continue to be redundant in my posts (my apologies), but we don't (we can't) get to that IND threshhold without the CypCap's and WCB.
Just got email from IR...unfortunately, they have yet to contract with new CRO.
I used to want the new CRO to get nailed down as quick as possible, but now, over the last two weeks I've been thinking that KW prefers not to spend the money on a CRO until the CypCaps and MCB are complete....just a guess on my part.
Go PMCB!!!!
Last we heard, alternative cells being worked with, and no update...also, no update on whether or not we've even corrected the original MC's
Personally, after the last CC I'm now in the dark even with a sense of direction on that front.
Of course, hoping some positive news comes through eventually.
LIGHT: dim
Go PMCB!!!
The potential of such an event to happen with PharmaCyte would be 100 times likelier and greater if both CypCaps and MCB is successfully produced. :) :) :)
(((((((((((Patience)))))))))))
Go PharmaCyte Team!!!!!
That my friend is this $64,000 question. I say continue with faith and patience.
lol Call me a party pooper!...
I could give two shits about a party.
Austrianova and Eurofins successfully producing and testing the CypCaps and MCB is all that matters to me.
Those two tasks are like climbing Mount Fuji and fkn Kilimanjaro from a bioengineering point of view.
Once we get over them, then I can honestly see a wonderful improvement to the lives of both patients and investors as I confidently presume the trials will too be successful. :) :) :)
Go PharmaCyte!!!
You damn skippy!!! :) :) :)
I’d rather be a stuffed pig then a slaughtered hog. :)
I’ll take success with PC without diabetes any day. :) :) :)
PC alone....way into dollar land.
Again, for PMCB, charts yield nothing. Come on KW! ...show us what “really” matters.
I hear that the peak of the Cali rally will go into mid February. So, ANY news of progress on our cannabinoid chemotherapy would certainly bump up the pps as new cannabis investors are flooding both American and Canadian markets.
CypCaps and MCB and we’re there! :) :) :)
Good close today :)
Big thumbs up! ...that would be sweet ...but, if it were up to me, with the potential of achieving all three major events (CypCaps, banks, IND), I would be preparing to separately PR each to incrementally boost the pps in order to maximize the share price. :) :) :)
Especially with all three being ready about the same time. There wouldn’t be much time for much of a pull back between each spike.
Want to hurry and get to dollar land before a reverse split happens.
silly ass drama...READ ACCOUNT TERMS AND CONDITIONS!!!!!
Hoping positve news is ahead. Without the CRO and the cell banks we’re still a long ways from getting out of the woods.
Patience.
Go PharmaCyte team!!!
Wish you all a very happy and prosperous new year!
NICE!!!
Yes, I agree...we’ll definitely be alright either way. :) :) :) ...Merry Christmas!
Think cause of effect...ACB significant customer...naturally, the better or stronger they get positioned, the better our prospects of repeat business (sales/profits) with them...favorable additional numbers to our bottom line results, correct?
If the CanniMed proxy is successful at getting the shareholders to reject the ACB deal, then for several reasons, there’s going to be some disappointment shared by many. jmo
I’m hoping so! ;) ;) ;)
We all are!
lol 2018, quiet???...are you crazy?!!!
2018 is it!!!!!!
Either the IND gets submitted, AND the trial gets going....or, the hope for this PC therapy will die.
These two events must happen in 2018.
Lets hope for the best.